Severity
Critical
FDA Drug recall · Reported May 13, 2015
Non-Sterility: The recalled lot failed sterility testing.
Physician Preferred Medical, LLC recalled Epel 18 mg Estradiol Pellet, For In Office Use Only, For In Office Administration Only, N… - a critical-severity action.
Epel 18 mg Estradiol Pellet, For In Office Use Only, For In Office Administration Only, N… was recalled by Physician Preferred Medical, LLC in May 13, 2015. Reason: Non-Sterility: The recalled lot failed sterility testing.. Check the official notice for the remedy. Verify recall #D-0982-2015 with the FDA Drug before acting.
The recall
Physician Preferred Medical, LLC issued this critical-severity FDA Drug recall-Non-Sterility: The recalled lot failed sterility testing..
Sourced from official FDA Drug enforcement records. Verify recall #D-0982-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0982-2015) was formally reported on May 13, 2015, with the manufacturer initiating the action on July 24, 2014. It is classified under Critical severity (Class I), with a current status of Terminated. Physician Preferred Medical, LLC is listed as the recalling firm, operating out of Oklahoma City, OK. Federal records list the affected scope as 122 Pellets.
The documented reason for this recall is: Non-Sterility: The recalled lot failed sterility testing. Distribution data in the federal record shows the product reached: AZ and KS. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
122 Pellets
Related Recalls
6
5 from same agency
Epel 18 mg Estradiol Pellet, For In Office Use Only, For In Office Administration Only, Not for Resale or Dispensing to an Individual Patient, Rx Only, Preferred Physician Medical LLC, 405-551-8216
Non-Sterility: The recalled lot failed sterility testing.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-0982-2015 |
| Date reported | May 13, 2015 |
| Date initiated | July 24, 2014 |
| Recalling firm | Physician Preferred Medical, LLC |
| Firm location | Oklahoma City, OK |
| Affected scope | 122 Pellets |
| Distribution | AZ and KS |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 13, 2015. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.